The “Innovations” TV program on the Discovery Channel recently featured the groundbreaking xCELLigence RTCA CardioECR system from ACEA Biosciences. In the clip shown here Dr. Blake Anson from Cellular Dynamics International describes the advantages of performing cardiotoxicity screening using hiPSC-derived cardiomyocytes and the xCELLigence CardioECR system. The complete program can be viewed here: https://www.youtube.com/watch?v=44bpQT3lCnk
Blake D. Anson, Ph.D.,
Cellular Dynamics International
Dr. Anson received his doctorate in Neuroscience, undertook postdoctoral training at the University of Wisconsin in Molecular Genetics examining structure/function relations in a variety of K+ channels, and then moved to an assistant scientist position in Cardiovascular Research under Dr. Craig T. January at the University of Wisconsin Medical School where he examined hERG channel physiology and pharmacology from healthy and clinical (Long QT) patients. Dr. Anson has been at Cellular Dynamics International since 2005 where he started as the Director of hERG Screening Services and has migrated into his current role as Product Manager.